Insider · CIK 0001851041
Bronson Crouch
Files at TIL (Instil Bio, Inc.). First filing -, latest -.
In brief
Bronson Crouch files SEC Form 4 as CEO, chair, director and 10% owner at TIL (Instil Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Bronson Crouch has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 25, 2025 | TIL Instil Bio, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +105,157 | $0.00 | $0 | 105,157 | Apr 28, 2025 |
Questions about Bronson Crouch
Answered from the filings on this page, as of the latest one.
Is Bronson Crouch buying or selling?
Bronson Crouch has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Bronson Crouch's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bronson Crouch has 0.
Where does Bronson Crouch file Form 4?
Bronson Crouch has filed Form 4 at TIL (Instil Bio, Inc.) as CEO and Chairman. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.